COVID-19 adaptive platform trials attending regularly | |
---|---|
Trial name | Trial identifier |
AMMURAVID | EudraCT2020-001854–23 |
ANTICOV | PACTR202006537901307 |
ACTIV-3 | NCT04501978 |
ACTIV STRIVE | NCT05605093 |
DisCoVeRya | EudraCT2020-000936–23 |
ECRAID-Primea | EU GA 101046109 |
EU-SolidActa | EudraCT2021-000541–41, EUCT2022-500385–99-00 |
MANTICO-2 | EudraCT2021-002612–31 |
PRINCIPLE | EudraCT2020-001209–22 |
PANORAMIC | EudraCT2021-005748–31 |
RECOVERY | EudraCT2020-001113–21 |
World Health Organization SOLIDARITY | EudraCT2020-001784–88 |
REMAP-CAPa | EudraCT2015-002340–14 |
MPX RESPONSEa | Cohort |
VACCELERATEa | EU GA 101037867, EudraCT2021-004526–29 and EudraCT2021-004889–35 |
COMCOV1 | EudraCT: 2020–005085-33 |
COMCOV2 | EudraCT: 2021–001275-16 |
COMCOV3 | EudraCT: 2021–004267-27 |
MonkeyVax | Cohort |